Drugplain

NDC 81968-045-30

AUVELITY 105 mg/1

dextromethorphan hydrobromide, bupropion hydrochloride · TABLET, MULTILAYER, EXTENDED RELEASE

No Recall History

AUVELITY is a tablet, multilayer, extended release containing dextromethorphan hydrobromide, bupropion hydrochloride at a strength of 105 mg/1. Manufactured by Axsome Therapeutics, Inc..

Key Facts

Brand Name
AUVELITY
Generic Name
dextromethorphan hydrobromide, bupropion hydrochloride
NDC Code (Package)
81968-045-30
NDC Code (Product)
81968-045
Manufacturer
Axsome Therapeutics, Inc.
Strength
105 mg/1
Dosage Form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Marketing Status
Application #
NDA215430
Marketing Start
08/18/2022

Recall History

No Recall History

View Full Drug Page

AUVELITY — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.